While exploring a digitally represented object through artificially created sense of touch, brain-computer interface users described the warm fur of a purring cat, the smooth rigid surface of a door ...
RAMAT GAN, Israel - XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) received a delisting notice from Nasdaq on Tuesday, according to a press release statement. The Nasdaq Stock Market ...
Research says that our health can suffer when we don’t experience enough physical contact. Here’s how to get more. Credit...Vanessa Saba Supported by By Christina Caron Allora Dannon, 35, an author ...
President Trump acknowledged in an interview on Wednesday that his administration could use a “softer touch” on immigration when asked what he learned from the fallout over the handling of the federal ...
FUJIFILM Dimatix Launches the DMP-2850 S Materials Printer Designed for Researchers and Universities
LEBANON, N.H.--(BUSINESS WIRE)--FUJIFILM Dimatix, Inc., a leading global manufacturer and supplier of piezoelectric, drop-on-demand industrial inkjet printheads, announced the launch of its new ...
RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced that it is working diligently to close the acquisition ...
Treasury Secretary Scott Bessent said he had spoken with his Japanese counterpart amid a selloff in Japan’s government bonds that he said had fed through to affect the Treasuries market. “I’ve been in ...
Beyond Air (NASDAQ: XAIR), majority owner of NeuroNOS, to hold 19.99% of XTL's post-transaction share capital Beyond Air to receive up to $32.5 million in upfront, development and commercial milestone ...
The consideration includes 19.9% of XTL's issued shares, $1 million in cash, and milestone-based contingent payments of up to $32.5 million. The transaction remains subject to customary closing ...
(RTTNews) - XTL Biopharmaceuticals Ltd. (XTLB), a biopharmaceutical company, Tuesday announced that it has agreed to acquire 85 percent of NeuroNOS Ltd., a subsidiary of Beyond Air, Inc. (XAIR), a ...
State Street® SPDR® S&P® Telecom ETF is upgraded to Buy for 2026, reflecting its evolution into a growth-focused, small/mid-cap telecom and AI infrastructure portfolio. XTL’s 2025 total return neared ...
Hosted on MSN
XTL Biopharmaceuticals takes major impairment on the Social Proxy in first-half 2025 results
XTL Biopharmaceuticals Sponsored ADR ( (XTLB)) has provided an announcement. On December 30, 2025, XTL Biopharmaceuticals reported financial results for the six months ended June 30, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results